Trials / Completed
CompletedNCT02131350
Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Shinshu University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the mean gain in best corrected visual acuity and the number of intravitreal ranibizumab (IVR) injections under the combination treatment of IVR, focal/grid laser and panretinal photocoagulation. Our hypothesis is that suitable photocoagulation decreases the number of IVR injections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Photocoagulation | Photocoagulation include focal/grid laser and/or panretinal photocoagulation |
| DRUG | Ranibizumab |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2017-03-01
- Completion
- 2018-03-01
- First posted
- 2014-05-06
- Last updated
- 2018-09-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02131350. Inclusion in this directory is not an endorsement.